載入...
Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature
Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Limited
2014-01-01
|
| 叢編: | BioMed Research International |
| 在線閱讀: | http://dx.doi.org/10.1155/2014/827327 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|